Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study

被引：2
|
作者：
Grattan, C. [1 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Dermatol Ctr, Colney NR4 7UY, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2014年 / 171卷 / 01期
关键词：
D O I：
10.1111/bjd.13112
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：8 / 9
页数：3
相关论文
共 50 条
  • [41] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (vol 71, pg 1135, 2016)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Brautigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2017, 72 (09) : 1430 - 1430
  • [42] Patients with h1-antihistamine-resistant chronic spontaneous urticaria have long disease duration and show little improvement in disease characteristics and burden with time
    Maurer, M.
    Staubach, P.
    Raap, U.
    Richter-Huhn, G.
    Chapman-Rothe, N.
    Baeumer, D.
    ALLERGY, 2018, 73 : 227 - 228
  • [43] Treatment impact on quality of life of patients with chronic urticaria refractory to at least one course of H1 antihistamine therapy: Real-world evidence from AWARE-LACan study
    Dabove, F.
    Chiaverini, Ensina L. F.
    Velasquez-Lopera, M.
    Quijano, L. M. T.
    Berroa, F.
    Di Tata, F.
    Tassinari, P.
    ALLERGY, 2020, 75 : 198 - 198
  • [44] A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria
    Ye, Y.
    Choi, J.
    Kim, M.
    Shin, Y.
    Park, H.
    ALLERGY, 2020, 75 : 85 - 86
  • [45] Real-world evidence from the AWARE study in Germany highlights the need for greater awareness of guideline recommendations for the treatment of patients with H1-antihistamine-refractory chronic spontaneous urticaria
    Maurer, M.
    Raap, U.
    Staubach, P.
    Richter-Huhn, G.
    Baemer, D.
    Chapman-Rothe, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 114 - 114
  • [46] H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study
    Maurer, M.
    Staubach, P.
    Raap, U.
    Richter-Huhn, G.
    Bauer, A.
    Rueff, F.
    Jakob, T.
    Yazdi, A. S.
    Mahler, V.
    Wagner, N.
    Lippert, U.
    Hillen, U.
    Schwinn, A.
    Pawlak, M.
    Behnke, N.
    Chaouche, K.
    Chapman-Rothe, N.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (05): : 684 - 692
  • [47] ANGIOEDEMA RESULTS FROM GLACIAL: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETYAND EFFICACY OF OMALIZUMAB IN PATIENTS WITH CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) RECEIVING CONCOMITANT H1 ANTI-HISTAMINES, H2 ANTIHISTAMINES, AND/OR LEUKOTRIENE RECEPTOR ANTAGONIST (LTRA) TREATMENT
    Zazzali, J.
    Raimundo, K.
    Ashby, M.
    Rosen, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A121 - A121
  • [48] The Urticaria Control Test as a Tool for Monitoring Chronic Idiopathic/Spontaneous Urticaria Treatment: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-controlled Study
    Kaplan, Allen P.
    Casale, Thomas B.
    Bernstein, Jonathan A.
    Holden, Michael
    Iqbal, Ahmar
    Trzaskoma, Benjamin L.
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB54 - AB54
  • [49] Ligelizumab as add-on therapy for patients with H1-antihistamine-refractory chronic spontaneous urticaria: Primary results of a placebo- and active-controlled phase 2b dose finding study
    Maurer, M.
    Gimenez-Arnau, A.
    Sussman, G.
    Loeffler, J.
    Barve, A.
    Severin, T.
    Janocha, R.
    ALLERGY, 2018, 73 : 837 - 837
  • [50] Efficacy of narrowband ultraviolet B phototherapy vs. low-dose oral ciclosporin as second-line management in antihistamine-refractory chronic spontaneous urticaria: a noninferiority, randomized study
    Roshini, N.
    Mehta, Hitaishi
    Bishnoi, Anuradha
    Parsad, Davinder
    Kumaran, Sendhil
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I94 - I94
12345